PMGC HOLDINGS INC. Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net
PMGC HOLDINGS INC. (ELAB) had Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net of $71.79 thousand as of 2025-01-16, per its 10-K filed 2026-03-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Disposal Group, Including Discontinued Operation, Assets, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet · last filed 2026-03-30
- 2025-01-16: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $71.79K.
- 2024-12-31: Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net $43.50K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net |
|---|---|
| 2025-01-16 | $71.79K 10-K · filed 2026-03-30 |
| 2024-12-31 | $43.50K 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |